Evidence of Increased Hemangioblastic and Early Hematopoietic Potential in Chronic Myeloid Leukemia (CML)-derived Induced Pluripotent Stem Cells (iPSC)
G. Telliam, O. Feraud, S. Baykal, F. Griscelli, J. Imeri, T. Latsis, A. Bennaceur Griscelli, A. TURHAN
This study shows that CML-derived iPSC have expanded hemangioblast and hematopoietic progenitor potential compared to H1-ESC, with AHR signaling as a potential therapeutic target.
bioRxiv · Jun 17, 2020Cancer Biology